ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

House Panel Seeks Information From Drug Cos. On Health Law Agreements With White House -Bloomberg

DOW JONES NEWSWIRES Republicans on the House Energy and Commerce Committee are seeking information from several large drug companies about their agreements with the Obama administration during the formation of the health-care reform law, Bloomberg News reported Friday, citing three people familiar with the talks. One of the people said the Republicans turned to direct negotiations with the companies after trade group Pharmaceutical Research and Manufacturers of America didn't cooperate, Bloomberg reported. The committee is seeking documents and other information from Pfizer Inc. (PFE), Merck & Co. (MRK), Amgen Inc. (AMGN), Abbott Laboratories (ABT) and AstraZeneca PLC (AZN), Bloomberg reported. Rep. Michael Burgess (R., Texas) told Bloomberg that "this has been like pulling teeth, trying to get information." A spokesman for PhRMA said "we have been cooperating with the committee on an ongoing basis since the investigation began," Bloomberg reported. Full story at http://www.bloomberg.com/news/2012-05-04/obama-deal-with-drugmakers-said-to-be-probed-by-house.html -Dow Jones Newswires; 212-416-2900

Stock News for Abbott Labs (ABT)
DateTimeHeadline
05/14/201310:21:08AbbVie, Alvine Pharma to Collaborate on Investigational Drug...
05/10/201317:20:41AbbVie Chief Scientific Officer John Leonard to Retire
04/30/201317:43:33BOND REPORT: Apple Prices $17 Bln Bond Deal To Strong Demand
04/30/201314:38:57BOND REPORT: Apple Launches $17 Bln Bond Deal
04/30/201313:47:14BOND REPORT: Apple Sees High Demand For Bond Offering
04/30/201311:58:44Auction of Brazilian Drug Company Ache Stalls on Differences...
04/26/201308:50:10AbbVie Profit Rises, Boosted by Humira Sales
04/26/201308:39:21AbbVie 1st-Quarter Profit Rises 9.6% on Strong Sales of Humira
04/23/201310:01:52Health-Care Companies Report Slowdown in Patient Visits
04/17/201308:42:49Abbott 1st-Quarter Profit Fell 56% On Spinoff; Remaining Operations...
04/15/201307:50:35Abbott Laboratories Recalls FreeStyle InsuLinx Glucose Meters
04/12/201309:01:10Elan Investors Back Buyback, As Takeover Speculation Swirls
04/05/201309:08:58U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
04/04/201317:00:42Appeals Court Reverses $593 Million Award Against J&J
04/04/201316:25:26U.S. Appeals Court Reverses $593 Million Award Against J&J
03/22/201315:50:41Abbott Labs Issues Safety Alert on MitraClip Heart-Valve Device
03/20/201319:01:03FDA Panel Votes 5-3 on Benefits of Abbott Heart Device Mitraclip
03/18/201311:00:33AbbVie CEO 2012 Compensation Valued at $7.9 Million, Up More...
03/18/201308:50:01FDA Recommends Against Approving Abbott's Mitraclip Heart Device
03/05/201300:31:11Rise of Generics, Specialty Drugs Prompt Shift in Drug Spending

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad